Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
China flag China · Delayed Price · Currency is CNY
12.78
+0.05 (0.39%)
May 8, 2026, 3:04 PM CST

SHE:002727 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
7,3377,3837,62513,80318,78222,959
Market Cap Growth
6.09%-3.16%-44.76%-26.51%-18.19%15.78%
Enterprise Value
6,7247,1567,67913,71719,10123,481
Last Close Price
12.7812.8612.6222.0329.5335.52
PE Ratio
26.3828.0366.8025.1218.6024.91
Forward PE
15.9612.4310.1713.0016.5919.48
PS Ratio
0.430.430.420.791.081.57
PB Ratio
0.960.991.001.752.503.44
P/TBV Ratio
1.401.461.442.333.204.52
P/FCF Ratio
4.635.455.207.418.7416.40
P/OCF Ratio
3.954.524.436.537.5212.81
PEG Ratio
-1.101.101.101.101.10
EV/Sales Ratio
0.400.410.430.791.101.61
EV/EBITDA Ratio
2.968.2615.5814.1613.3418.30
EV/EBIT Ratio
8.949.6020.0416.2514.5019.81
EV/FCF Ratio
4.255.285.247.378.8916.77
Debt / Equity Ratio
0.330.350.400.380.410.44
Debt / EBITDA Ratio
1.111.161.861.501.331.28
Debt / FCF Ratio
1.601.952.071.611.442.08
Net Debt / Equity Ratio
-0.10-0.06-0.05-0.11-0.060.06
Net Debt / EBITDA Ratio
-0.88-0.49-0.78-0.93-0.300.29
Net Debt / FCF Ratio
-0.49-0.31-0.26-0.48-0.200.27
Asset Turnover
1.041.071.081.061.141.23
Inventory Turnover
2.993.013.133.263.433.38
Quick Ratio
0.760.720.700.800.820.70
Current Ratio
1.351.301.271.371.381.31
Return on Equity (ROE)
3.73%3.60%1.42%7.28%14.27%14.73%
Return on Assets (ROA)
2.88%2.87%1.43%3.21%5.40%6.26%
Return on Invested Capital (ROIC)
7.21%6.97%2.86%9.56%15.28%20.17%
Return on Capital Employed (ROCE)
8.50%8.50%4.20%8.90%14.20%14.00%
Earnings Yield
3.80%3.57%1.50%3.98%5.38%4.01%
FCF Yield
21.59%18.35%19.22%13.49%11.44%6.10%
Dividend Yield
3.14%-2.38%1.82%1.35%0.84%
Payout Ratio
108.91%115.74%228.27%47.40%18.97%19.63%
Buyback Yield / Dilution
2.28%2.70%0.76%-0.27%-0.50%-3.32%
Total Shareholder Return
5.42%2.70%3.13%1.55%0.85%-2.48%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.